These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1499 related articles for article (PubMed ID: 19617601)

  • 1. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.
    Burkhoff D; Cohen H; Brunckhorst C; O'Neill WW;
    Am Heart J; 2006 Sep; 152(3):469.e1-8. PubMed ID: 16923414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.
    Thiele H; Sick P; Boudriot E; Diederich KW; Hambrecht R; Niebauer J; Schuler G
    Eur Heart J; 2005 Jul; 26(13):1276-83. PubMed ID: 15734771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support.
    Boeken U; Feindt P; Litmathe J; Kurt M; Gams E
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):324-8. PubMed ID: 19707972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials.
    Thiele H; Jobs A; Ouweneel DM; Henriques JPS; Seyfarth M; Desch S; Eitel I; Pöss J; Fuernau G; de Waha S
    Eur Heart J; 2017 Dec; 38(47):3523-3531. PubMed ID: 29020341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Machemer MT; Solms A; Thiele H; Burkhoff D; Seyfarth M; de Waha A; Ohman EM; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007398. PubMed ID: 21735410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical circulatory support in cardiogenic shock.
    Werdan K; Gielen S; Ebelt H; Hochman JS
    Eur Heart J; 2014 Jan; 35(3):156-67. PubMed ID: 24014384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
    Li JL; Xue H; Wang BS; Zhang HY; Yin LH; Shun WD; Wu Y; Wang LX
    Med Sci Monit; 2007 Jun; 13(6):CR270-74. PubMed ID: 17534233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock.
    Burkhoff D; O'Neill W; Brunckhorst C; Letts D; Lasorda D; Cohen HA
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):211-7. PubMed ID: 16819767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percutaneous ventricular assist device in severe refractory cardiogenic shock.
    Kar B; Gregoric ID; Basra SS; Idelchik GM; Loyalka P
    J Am Coll Cardiol; 2011 Feb; 57(6):688-96. PubMed ID: 20950980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Buerke M; de Waha A; Haerting J; Pietzner D; Seyfarth M; Thiele H; Werdan K; Zeymer U; Prondzinsky R
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD007398. PubMed ID: 25812932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-Aortic Balloon Pump (IABP) in cardiogenic shock.
    Fuernau G; Thiele H
    Curr Opin Crit Care; 2013 Oct; 19(5):404-9. PubMed ID: 23995129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.